RASF-Clinical Research Center

Boca Raton, Florida 33486-1390

2 studies enrolling now · 23 studies all time

What they study most

Ankylosing Spondylitis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Osteoarthritis, Hip, Osteoarthritis, Knee, Osteoporosis, Psoriatic Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis

Studies at this site

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines — Recruiting now
• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines — Recruiting now
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants — Completed
• A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Completed
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
• A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis — Stopped early
• Open Label Extension Study of PREOS — Completed
• TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis — Completed
• A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections — Stopped early
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Stopped early
• Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) — Completed
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab — Stopped early
• A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350 — Completed
• Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) — Completed
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed
• Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) — Completed
• Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects — Completed
• Treatment of Rheumatoid Arthritis With Marine and Botanical Oils — Status unconfirmed